Moneycontrol PRO
covid 19 vaccine
Jump to
  • Health Ministry reduces gap between second vaccine dose and booster dose Jul 06, 2022 05:42 PM IST

    Health Ministry reduces gap between second vaccine dose and booster dose

    The COVID-19 booster dose gap for adult beneficiaries in India has been lowered from the previously decided nine-month period to a six-month period by the Union Health Ministry. The National Technical Advisory Group on Immunization's advice served as the foundation for the decision.

  • mRNA booster shot in pipeline, says Gennova Biopharmaceuticals Jun 29, 2022 06:08 PM IST

    mRNA booster shot in pipeline, says Gennova Biopharmaceuticals

    After getting the nod from India's drug regulator, Gennova Biopharmaceuticals is now aiming for WHO approval for its mRNA vaccine

  • US rolls out COVID-19 vaccines for children under five Jun 23, 2022 01:14 PM IST

    US rolls out COVID-19 vaccines for children under five

    The United States has delivered about 2.7 million doses of COVID vaccines for children below five years to administration centres while another one million shots will reach the sites soon, the Department of Health and Human Services said on June 22.

  • Paraguay cancels order for one million Covaxin doses citing quality issues: Reports Jun 07, 2022 11:03 PM IST

    Paraguay cancels order for one million Covaxin doses citing quality issues: Reports

    Bharat Biotech did not immediately react to the development, but company sources reportedly said that all export orders already stand cancelled as the production has been halted.

  • FDA advisers meeting on Novavax, a latecomer in vaccine race Jun 07, 2022 06:53 PM IST

    FDA advisers meeting on Novavax, a latecomer in vaccine race

    A federal advisory committee Tuesday will vote on whether regulators should authorize a COVID-19 vaccine made by Novavax, an early beneficiary of the government’s Operation Warp Speed program.

  • Pfizer to offer low-cost medicines, vaccines to world's poorest countries May 25, 2022 12:42 PM IST

    Pfizer to offer low-cost medicines, vaccines to world's poorest countries

    US pharmaceutical giant Pfizer on Wednesday said it would sell its patented drugs at a not-for-profit basis to the world's poorest countries, as part of a new initiative announced at the World Economic Forum in Davos.

  • Pfizer/BioNTech say 3 COVID shots elicit good response in children under 5 May 23, 2022 09:17 PM IST

    Pfizer/BioNTech say 3 COVID shots elicit good response in children under 5

    Drugmakers Pfizer Inc and BioNTech SE said on Monday that three doses of their COVID-19 vaccine generated a strong immune response in children under age 5 and was safe and well-tolerated in their clinical trial.

  • The COVID pandemic is ‘most certainly not over’: WHO chief Tedros Adhanom Ghebreyesus May 23, 2022 05:09 PM IST

    The COVID pandemic is ‘most certainly not over’: WHO chief Tedros Adhanom Ghebreyesus

    The UN health agency’s director-general, Tedros Adhanom Ghebreyesus, told officials gathered in Geneva for opening of the WHO’s annual meeting that “declining testing and sequencing means we are blinding ourselves to the evolution of the virus.” He also noted that almost 1 billion people in lower-income countries still haven’t been vaccinated.

  • Pfizer/BioNTech say 3 COVID shots generate good response in under-5s May 23, 2022 04:42 PM IST

    Pfizer/BioNTech say 3 COVID shots generate good response in under-5s

    The companies said the vaccine was safe and well-tolerated by the children, and they plan to soon ask global regulators to authorize the shot for the age group, children for whom no vaccine is currently approved in most of the world.

  • AstraZeneca's COVID jab Vaxzevria wins EU approval as booster May 23, 2022 02:30 PM IST

    AstraZeneca's COVID jab Vaxzevria wins EU approval as booster

    "Healthcare professionals can now use Vaxzevria as a third dose booster in patients previously given a primary vaccine schedule of either Vaxzevria or an EU-approved mRNA COVID-19 vaccine."

  • Over 191.91 crore COVID vaccine doses administered in India: Govt May 20, 2022 06:44 AM IST

    Over 191.91 crore COVID vaccine doses administered in India: Govt

    A total of 47,761 precaution doses of COVID-19 vaccine were administered to beneficiaries aged 18-59 years till 7 pm, taking the total number of such doses given in this age-group to 16,25,744 so far, according to the ministry’s data.

  • US CDC urges Pfizer booster for children ages 5 to 11 May 20, 2022 06:23 AM IST

    US CDC urges Pfizer booster for children ages 5 to 11

    Pfizer and its partner BioNTech currently make the only COVID-19 vaccine available for children of any age in the U.S. Those ages 5 to 11 receive a dose that’s one-third the amount given to everyone 12 and older.

  • WHO authorises China's CanSinoBIO COVID-19 vaccine May 19, 2022 05:23 PM IST

    WHO authorises China's CanSinoBIO COVID-19 vaccine

    "The vaccine meets WHO standards for protection against Covid-19 and... the benefits of the vaccine far outweigh risks," the UN health agency said in a statement.

  • US FDA authorizes Pfizer's COVID booster shot for young children May 17, 2022 08:22 PM IST

    US FDA authorizes Pfizer's COVID booster shot for young children

    The authorization makes everyone in the United States aged five and above eligible for booster doses of the vaccine.

  • COVID-19 update | International travellers to receive booster dose 3 months after second shot: Govt May 11, 2022 07:46 PM IST

    COVID-19 update | International travellers to receive booster dose 3 months after second shot: Govt

    Currently, Covid-19 vaccine booster doses are available to all above 18 years on the condition that the beneficiary has completed 9 months since their second shot.

  • Fourth COVID-19 vaccine dose provides strong immunity boost: UK study May 11, 2022 03:25 PM IST

    Fourth COVID-19 vaccine dose provides strong immunity boost: UK study

    The findings, published in The Lancet Infectious Disease journal, show that fourth dose mRNA booster vaccines for COVID-19 are well-tolerated in people who received Pfizer as a third dose.

  • The White House plans for how to provide vaccines if there Is no more COVID-19 aid May 07, 2022 11:01 PM IST

    The White House plans for how to provide vaccines if there Is no more COVID-19 aid

    Democrats have been contemplating wrapping COVID-19 aid into another emergency package for Ukraine, but it was unclear whether they will do so.

  • India's cumulative COVID-19 vaccine doses administered crosses 190 crore-mark May 07, 2022 12:05 PM IST

    India's cumulative COVID-19 vaccine doses administered crosses 190 crore-mark

    All those above the age of 18 who have completed nine months after the administration of the second dose are eligible for the precaution dose.

  • Covid-19: 10 crore doses of SII's Covovax approved for exports by govt lab, stock rolled out for teens May 05, 2022 09:36 PM IST

    Covid-19: 10 crore doses of SII's Covovax approved for exports by govt lab, stock rolled out for teens

    Covovax, the Covid-19 vaccine manufactured by the Serum Institute of India under licence from US firm Novavax, will be available at Rs 225 per dose, excluding taxes, at private healthcare facilities.

  • COVID-19 shots may be required on an annual basis in the future: USFDA May 05, 2022 09:52 AM IST

    COVID-19 shots may be required on an annual basis in the future: USFDA

    They also opined that the virus will likely circulate globally, with other prevalent respiratory viruses like influenza. It was also stated by them that this scenario almost certainly necessitates the same level of annual consideration for vaccine composition revisions.

  • Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-old May 04, 2022 04:46 PM IST

    Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-old

    Presently, precaution dose of Covaxin and Covishield is administered to all those aged above 18 who have completed nine months after the second dose.

  • COVID-19 Vaccination India | Covovax is now available for children aged 12-17 years: Adar Poonawalla May 03, 2022 04:45 PM IST

    COVID-19 Vaccination India | Covovax is now available for children aged 12-17 years: Adar Poonawalla

    Covovax is the only vaccine manufactured in India that is also sold in Europe and has an efficacy of over 90 percent, Poonawalla said while making the announcement on Twitter.

  • SII's COVID-19 vaccine Covovax now available for 12-17 age group at private centres May 02, 2022 09:24 PM IST

    SII's COVID-19 vaccine Covovax now available for 12-17 age group at private centres

    A dose of Covovax will cost Rs 900 plus GST at private vaccination centres, in addition to a hospital service charge of Rs 150.

  • Moneycontrol Selects: Top stories this evening Apr 29, 2022 10:05 PM IST

    Moneycontrol Selects: Top stories this evening

    Our specially curated package of the most interesting articles of the day will help you stay at the top of your game.

  • COVID-19 update | NTAGI recommends Covovax for use in 12-17-year-olds in India Apr 29, 2022 05:50 PM IST

    COVID-19 update | NTAGI recommends Covovax for use in 12-17-year-olds in India

    This is the Indian version of the COVID-19 vaccine, manufactured by the the US based Novavax.

Sections
ISO 27001 - BSI Assurance Mark